- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1129-2377
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
New drugs for migraine ; volume:10 ; number:6 ; day:1 ; month:10 ; year:2009 ; pages:395-406 ; date:12.2009
The journal of headache and pain ; 10, Heft 6 (1.10.2009), 395-406, 12.2009
- Urheber
-
Stovner, Lars Jacob
Tronvik, Erling
Hagen, Knut
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10194-009-0156-9
- URN
-
urn:nbn:de:101:1-2021082320195782463015
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Stovner, Lars Jacob
- Tronvik, Erling
- Hagen, Knut
- SpringerLink (Online service)
Ähnliche Objekte (12)
New Oral Drugs for Migraine
Migraine drugs
Therapeutic novelties in migraine: new drugs, new hope?
Correction to: Therapeutic novelties in migraine: new drugs, new hope?
The history and rationale of the development of new drugs for migraine treatment
Optimising migraine treatment: from drug-drug interactions to personalized medicine
Proteome-wide Mendelian randomization identified potential drug targets for migraine
New directions in migraine
Are the current IHS guidelines for migraine drug trials being followed?
Drug treatment of migraine and other headaches : 58 tables
Histamine and migraine revisited: mechanisms and possible drug targets
Shaping the future of migraine targeting Calcitonin-Gene-Related-Peptide with the Disease-Modifying Migraine Drugs (DMMDs)
New Oral Drugs for Migraine
Migraine drugs
Therapeutic novelties in migraine: new drugs, new hope?
Correction to: Therapeutic novelties in migraine: new drugs, new hope?
The history and rationale of the development of new drugs for migraine treatment
Optimising migraine treatment: from drug-drug interactions to personalized medicine
Proteome-wide Mendelian randomization identified potential drug targets for migraine
New directions in migraine
Are the current IHS guidelines for migraine drug trials being followed?
Drug treatment of migraine and other headaches : 58 tables
Histamine and migraine revisited: mechanisms and possible drug targets
Shaping the future of migraine targeting Calcitonin-Gene-Related-Peptide with the Disease-Modifying Migraine Drugs (DMMDs)
New Oral Drugs for Migraine
Migraine drugs
Therapeutic novelties in migraine: new drugs, new hope?
Correction to: Therapeutic novelties in migraine: new drugs, new hope?
The history and rationale of the development of new drugs for migraine treatment
Optimising migraine treatment: from drug-drug interactions to personalized medicine
Proteome-wide Mendelian randomization identified potential drug targets for migraine
New directions in migraine
Are the current IHS guidelines for migraine drug trials being followed?
Drug treatment of migraine and other headaches : 58 tables
Histamine and migraine revisited: mechanisms and possible drug targets